Dr. Reddy's Laboratories outperforms market despite losses on the day
Dr. Reddy's Laboratories Ltd. closed 14.67% below its 52-week high of 1,420.20 rupees, which the company achieved on August ...
Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories shows resilience with low beta
Discover the Dr Reddys Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent ...
Dr. Reddy's Laboratories outperforms market on strong trading day
Dr. Reddy's Laboratories Ltd. closed 12.64% short of its 52-week high of 1,420.20 rupees, which the company achieved on ...
Daily3d
Dr. Reddy's Labs Gets CDSCO Panel Nod To Manufacture, Market Esomeprazole Gastro resistant capsules
This came after Dr. Reddy's Lab presented the proposal for grant of permission to manufacture and market Esomeprazole Gastro ...
Hosted on MSN7d
Dr. Reddy’s Laboratories Engages with Investors in Upcoming Conferences
An announcement from Dr Reddy’s Laboratories ( ($RDY) ) is now available. On February 4, 2025, Dr. Reddy’s Laboratories announced its ...
Morningstar2d
Dr Reddy's Laboratories Ltd
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Dr. Reddy's Lab: Near-Term Worries And Underappreciated Potential Could Lead To Huge Returns
Dr. Reddy's Lab is poised to witness crosswinds from a drop in revenue from the patent expiration of Revlimid and increased ...
GlobalData on MSN4d
Dr Reddy’s and Shanghai Henlius sign agreement for HLX15
A recombinant anti-CD38 fully human monoclonal antibody injection, HLX15 comes in both intravenous and subcutaneous ...
Dr Reddy’s arm ties up with Shanghai Henlius Biotech
New Delhi: Dr Reddy’s Laboratories on Thursday said its subsidiary has inked a licence agreement with Shanghai Henlius ...
Business Wire5d
Dr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories SA, wholly-owned subsidiary of Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY ...
Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.
Shanghai Henlius Biotech, Inc. (2696.HK) today announced it has entered into a license agreement with Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd., (BSE: ...